Literature DB >> 396080

Studies on the mechanism of mineralocorticoid-induced blood pressure increase in man.

A Distler, T Philipp, B Lüth, G Wucherer.   

Abstract

1. To gain insight into the mechanism of mineralocorticoid-induced blood pressure rise in man we performed haemodynamic studies in six normotensive volunteer subjects before and during administration of the synthetic steroid 9 alpha-fluorocortisol (0.8 mg daily) for a period of 6 weeks. In a further study, performed in seven subjects, plasma noradrenaline concentration and reactivity to exogenous noradrenaline were determined before and during administration of the mineralocorticoid. 2. Within the first week of steroid administration an increase in mean arterial blood pressure could be demonstrated, which was due to an increase in cardiac output. After the sixth week the elevated blood pressure was the consequence of an increased total peripheral resistance. 3. Plasma noradrenaline concentration decreased and reactivity to exogenous noradrenaline increased during steroid administration. 4. The mechanism underlying the increase in total peripheral resistance during long-term mineralocorticoid administration remains unclear. Increased sympathetic tone does not seem to be a factor since plasma noradrenaline decreased considerably. Pressor response to noradrenaline increased probably due to decreased sympathetic tone.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 396080     DOI: 10.1042/cs057303s

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  3 in total

Review 1.  Drug-induced hypertension. Recognition and management in older patients.

Authors:  P W de Leeuw
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

2.  Hypertensive crisis during the resection of an adrenal tumor in primary aldosteronism.

Authors:  H Otsuka; M Imai; O Kemmotsu
Journal:  J Anesth       Date:  1993-04       Impact factor: 2.078

3.  Conventional Vasopressor and Vasopressor-Sparing Strategies to Counteract the Blood Pressure-Lowering Effect of Small Interfering RNA Targeting Angiotensinogen.

Authors:  Estrellita Uijl; Dien Ye; Liwei Ren; Katrina M Mirabito Colafella; Richard van Veghel; Ingrid M Garrelds; Hong S Lu; Alan Daugherty; Ewout J Hoorn; Paul Nioi; Don Foster; A H Jan Danser
Journal:  J Am Heart Assoc       Date:  2022-07-25       Impact factor: 6.106

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.